Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

DNA Vaccines Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024


 

Available formats:    

StumbleUponEmail

Global DNA Vaccines Market

 

By Type (Monovalent Vaccines, Multivalent Vaccines), By Technology (Recombinant Vaccines, Inactivated and Subunit Vaccines, Conjugate Vaccines, Toxoid Vaccines, Live Attenuated Vaccines), By Disease Indication (Human Papilloma Virus (HPV), Pneumococcal Disease, Influenza, Meningococcal Disease, MMR (measles, mumps, and rubella), Dengue, Polio, Others), By Route of Administration (Oral Administration, Intramuscular and Subcutaneous Administration, Others),  and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018-2024

 

Global DNA vaccines market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2023

 

Market Outline: DNA Vaccines Market

Vaccination stimulates the immune system which has the disease causing agent that are modified in such a way that no harm is caused to the host. The DNA vaccination is a novel technique. DNA vaccines have various advantages when compared to conventional vaccines. They have the capacity of inducing a broad range of immune response. The DNA vaccination is a considered to be a radical approach in the vaccination. The vaccines are developed by not only using the DNA, but also has adjuncts which assist the DNA to enter the target specific cells.

 

Market Dynamics: DNA Vaccines Market

The rapid developments in the DNA synthesis, immunobiology, and molecular biology is the major factor anticipated the drive the growth of the DNA vaccines market. These modern technologies allows the manufacturers to development of the new vaccines. According to the World Health Organization (WHO) there are approximately 18 million people die owing to the drought of potent treatment for the infectious diseases which expected to provide the opportunity for the manufacturers to focus on research and development activities for the infectious diseases. Due its target specificity, these vaccines are gaining popularity which is creating a substantial new market. However, the strict government regulations are likely to hinder the growth of the DNA vaccines market.

 

Market Scope: DNA Vaccines Market

DNA vaccines market is segmented based on the type, technology, disease indication, route of administration, and end user.

Based on the type, the market is segmented into the following:

  • Monovalent Vaccines
  • Multivalent Vaccines

Based on the technology, the market is segmented into the following:

  • Recombinant Vaccines
  • Inactivated and Subunit Vaccines
  • Conjugate Vaccines
  • Toxoid Vaccines
  • Live Attenuated Vaccines

Based on the disease indication, the market is segmented into the following:

  • Human Papilloma Virus (HPV)
  • Pneumococcal Disease
  • Influenza
  • Meningococcal Disease
  • MMR (measles, mumps, and rubella)
  • Dengue
  • Polio
  • Others

Based on the route of administration, the market is segmented into the following:

  • Oral
  • Parenteral
  • Others

 

Regional Analysis:  DNA Vaccines Market

Geographically, global DNA vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America DNA vaccines market is growing due to the adoption of novel vaccines in the region. The awareness about the modern treatment methods among the healthcare fraternity is anticipated to drive the growth of the market in this region. Following the North American region are the regions of Europe and Asia Pacific are exhibiting significant revenue growth. The Asia Pacific is expected to show rapid growth over the forecasted period.

 

Competition Assessment: DNA Vaccines Market

Some of the players in the global DNA vaccines market include:

  • Merck & Co., Inc. (U.S.),
  • Sanofi Pasteur SA (France),
  • Astellas Pharma Inc. (Japan)
  • GlaxoSmithKline, plc (U.K.),
  • Pfizer, Inc. (U.S)
  • CSL Limited (Australia),
  • Emergent BioSolutions, Inc. (U.S.),
  • Panacea Biotec (India)
  • Protein Sciences Corporation (U.S)
  • Bavarian Nordic (Denmark)

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  1. Executive Summary
  2. Global DNA Vaccines Market Introduction
    • Global DNA Vaccines Market – Taxonomy
    • Global DNA Vaccines Market –Definitions
      • Type
      • Technology
      • Disease Indication
      • Route of Administration
  1. Global DNA Vaccines Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global DNA Vaccines Market Dynamic Factors – Impact Analysis
    • Global DNA Vaccines Market – Competition Landscape
    • Epidemiology
  2. Global DNA Vaccines Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global DNA Vaccines Market, By Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Monovalent Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Multivalent Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global DNA Vaccines Market Forecast, By Technology, 2013 – 2017 and Forecast, 2018 – 2024
    • Recombinant Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Inactivated and Subunit Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Conjugate Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Toxoid Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Live Attenuated Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global DNA Vaccines Market Forecast, By Disease Indication, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Human Papilloma Virus (HPV)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Pneumococcal Disease
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Influenza
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Meningococcal Disease
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • MMR (measles, mumps, and rubella)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Dengue
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Polio
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global DNA Vaccines Market Forecast, By Route of Administration, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Oral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Parenteral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global DNA Vaccines Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global DNA Vaccines Market – Opportunity Analysis Index, By Type, By Technology, By Disease Indication, By Route of Administration, and Region, 2018 – 2024
  2. North America DNA Vaccines MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Monovalent Vaccines
      • Multivalent Vaccines
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Recombinant Vaccines
      • Inactivated and Subunit Vaccines
      • Conjugate Vaccines
      • Toxoid Vaccines
      • Live Attenuated Vaccines
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Human Papilloma Virus (HPV)
      • Pneumococcal Disease
      • Influenza
      • Meningococcal Disease
      • MMR (measles, mumps, and rubella)
      • Dengue
      • Polio
      • Others
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
      • Others
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America DNA Vaccines Market – Opportunity Analysis Index, By Type, By Technology, By Disease Indication, By Route of Administration, and Country, 2018 – 2024
    • North America DNA Vaccines Market Dynamics – Trends
  3. Europe DNA Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Monovalent Vaccines
      • Multivalent Vaccines
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Recombinant Vaccines
      • Inactivated and Subunit Vaccines
      • Conjugate Vaccines
      • Toxoid Vaccines
      • Live Attenuated Vaccines
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Human Papilloma Virus (HPV)
      • Pneumococcal Disease
      • Influenza
      • Meningococcal Disease
      • MMR (measles, mumps, and rubella)
      • Dengue
      • Polio
      • Others
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe DNA Vaccines Market – Opportunity Analysis Index, By Type, By Technology, By Disease Indication, By Route of Administration, and Country, 2018 – 2024
    • Europe DNA Vaccines Market Dynamics – Trends
  4. Asia-Pacific DNA Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Monovalent Vaccines
      • Multivalent Vaccines
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Recombinant Vaccines
      • Inactivated and Subunit Vaccines
      • Conjugate Vaccines
      • Toxoid Vaccines
      • Live Attenuated Vaccines
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Human Papilloma Virus (HPV)
      • Pneumococcal Disease
      • Influenza
      • Meningococcal Disease
      • MMR (measles, mumps, and rubella)
      • Dengue
      • Polio
      • Others
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
      • Others
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific DNA Vaccines Market – Opportunity Analysis Index, By Type, By Technology, By Disease Indication, By Route of Administration, and Country, 2018 – 2024
    • Asia-Pacific DNA Vaccines Market Dynamics – Trends
  5. Latin America DNA Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Monovalent Vaccines
      • Multivalent Vaccines
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Recombinant Vaccines
      • Inactivated and Subunit Vaccines
      • Conjugate Vaccines
      • Toxoid Vaccines
      • Live Attenuated Vaccines
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Human Papilloma Virus (HPV)
      • Pneumococcal Disease
      • Influenza
      • Meningococcal Disease
      • MMR (measles, mumps, and rubella)
      • Dengue
      • Polio
      • Others
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America DNA Vaccines Market – Opportunity Analysis Index, By Type, By Technology, By Disease Indication, By Route of Administration, and Country, 2018 – 2024
    • Latin America DNA Vaccines Market Dynamics – Trends
  6. Middle East and Africa DNA Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Monovalent Vaccines
      • Multivalent Vaccines
    • Technology Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Recombinant Vaccines
      • Inactivated and Subunit Vaccines
      • Conjugate Vaccines
      • Toxoid Vaccines
      • Live Attenuated Vaccines
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Human Papilloma Virus (HPV)
      • Pneumococcal Disease
      • Influenza
      • Meningococcal Disease
      • MMR (measles, mumps, and rubella)
      • Dengue
      • Polio
      • Others
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA DNA Vaccines Market – Opportunity Analysis Index, By Type, By Technology, By Disease Indication, By Route of Administration, and Country, 2018 – 2024
    • MEA DNA Vaccines Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Merck & Co., Inc. (U.S.),
      • Sanofi Pasteur SA (France),
      • Astellas Pharma Inc. (Japan)
      • GlaxoSmithKline, plc (U.K.),
      • Pfizer, Inc. (U.S)
      • CSL Limited (Australia),
      • Emergent BioSolutions, Inc. (U.S.),
      • Panacea Biotec (India)
      • Protein Sciences Corporation (U.S)
      • Bavarian Nordic (Denmark)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

 

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553